HCP
58
4
AIV
68
-4
A
36
2
HSY
34
3
PVH
52
-3
IP
70
2
MRO
55
3
VTR
49
-3
ETR
68
3
AFL
46
-3
DLTR
34
-4
LH
42
2
AXP
66
2
COP
56
2
VRTX
46
2
IR
63
3
DVA
72
2
EFX
32
2
WMT
74
2
HAS
30
2
HCP
58
4
AIV
68
-4
A
36
2
HSY
34
3
PVH
52
-3
IP
70
2
MRO
55
3
VTR
49
-3
ETR
68
3
AFL
46
-3
DLTR
34
-4
LH
42
2
AXP
66
2
COP
56
2
VRTX
46
2
IR
63
3
DVA
72
2
EFX
32
2
WMT
74
2
HAS
30
2
Financhill
Back

Madrigal Pharmaceuticals Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Buy
57

MDGL
Madrigal Pharmaceuticals

Last Price:
320.90
Seasonality Move:
35.27%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Madrigal Pharmaceuticals Price Quote

$320.90
+3.81 (+1.2%)
(Updated: November 21, 2024 at 11:00 AM ET)

Madrigal Pharmaceuticals Key Stats

Buy
57
Madrigal Pharmaceuticals (MDGL) is a Buy
Day range:
$310.84 - $323.99
52-week range:
$168.25 - $368.29
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
8.52%
Volume:
277.2K
Avg. volume:
522.6K
1-year change:
66.85%
Market cap:
$6.6B
Revenue:
$0
EPS:
$-25.12

How Much Does Madrigal Pharmaceuticals Make?

Data Unavailable

Is Madrigal Pharmaceuticals Growing As A Company?

Data Unavailable

Madrigal Pharmaceuticals Stock Price Performance

What Is Madrigal Pharmaceuticals 52-Week High & Low?

Madrigal Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Madrigal Pharmaceuticals?

Is Madrigal Pharmaceuticals Cash Flow Positive?

  • What Is MDGL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$431M
  • What Is Madrigal Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.2B
  • What Is Madrigal Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$588.6M

Madrigal Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    MDGL return on invested capital is -74.25%
  • What Is Madrigal Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -62.74%
  • What Is MDGL Return On Equity?
    ROE is a measure of profitability and is -89.04%

Madrigal Pharmaceuticals Earnings Date & Stock Price

Madrigal Pharmaceuticals Competitors

Madrigal Pharmaceuticals Dividend Yield

Madrigal Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.8%
Revenue: 0% 80.67%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 368.87
Upside from Last Price: 16.33%

Major Shareholders

  • How many MDGL shares are owned by institutional investors?
    36M MDGL shares are owned by institutional investors
  • How many MDGL shares are owned by insiders?
    9M MDGL shares are owned by insiders